Even though Nike has outlined a plan to streamline its portfolio, analysts note that it would be some time before the sportswear company can revive demand as innovation and launches of new product lines take time.
The lawsuit alleges that Michael Shvo lured the glamorous, business-and cultural-focused Core Club to 711 Fifth Ave. – a building he claimed to own – with “sinister and fraudulent” schemes.
Nike is struggling to sell clothing and apparel and those “near-term challenges” prompted the retail giant to post one ofits slowest annual sales periods in years . Read more...
Target plans to crack down on retail theft by lowering the threshold for how much shoplifters can swipe before employees are allowed to finally step in.
Disney World will now allow guests to book ride reservations weeks in advance as part of the company’s effort to stem customer complaints about long wait times, the company announced Tuesday. Read more...
The justices ruled in a 6-3 vote that people accused of fraud by the SEC, which regulates securities markets, have the right to a jury trial in federal court.
The U.S. Supreme Court just struck down a key tool used by the Securities and Exchange Commission (SEC) to enforce laws against securities fraud in a major win for billionaires such as Tesla CEO Elon Musk. Read more...
The artificial intelligence company has signed similar deals over the past few months with the The Post parent News Corp, Financial Times and Business Insider-owner Axel Springer.
Walgreens announced it will be cutting its profit forecast for the fiscal 2024 year and closing more stores across the US in its latest attempt to deal with a "difficult operating environment."
The United States Supreme Court rejected on Thursday a nationwide, multi-billion dollar settlement involving OxyCotin maker Purdue Pharma. The rejected settlement would have provided billions of dollars to programs combating the nation’s opioid epidemic. It would have also
Ozempic maker Novo Nordisk is gearing up to launch its popular weight loss drug Wegovy in China, but it plans to restrict initial sales of the medication in order to not deplete supply for the rest of the world. Read more...